Understanding Blood Cancer: Types, Causes, Symptoms, and Treatment Outlook

Blood cancer is not a single disorder, rather it refers to a group of cancers that affect the blood, bone marrow, or lymphatic system. These cancers disrupt the normal production and function of blood cells, leading to symptoms that may appear gradually or resemble common infections, making early recognition challenging. To help ensure timely diagnosis and appropriate care, this article provides an overview of the major types of blood cancer, common risk factors, early warning signs, diagnostic methods, and treatment outlook. Let’s start with the basics. 

What is Blood Cancer?

Blood cancer is a broad term for cancers that affect the blood, bone marrow, or lymphatic system. These cancers begin when abnormal cells grow uncontrollably, interfering with the body’s ability to produce healthy blood cells. Since blood cells are responsible for carrying oxygen, fighting infections, and controlling bleeding, any disruption in their function can affect overall health. Blood cancer develops in tissues such as:

• Bone marrow, where new blood cells are formed
• Lymph nodes and lymphatic tissues, which support the immune system
• Circulating blood, where abnormal cells may multiply

Unlike solid tumours that form a mass, blood cancers can spread throughout the body through the bloodstream or lymphatic system. This is why early detection and specialised evaluation are important for identifying the type of blood cancer and planning appropriate treatment.

Types of Blood Cancer

Blood cancer includes several distinct diseases, each affecting different types of blood cells and presenting in unique ways. Understanding these categories helps clarify how the condition develops, how it behaves, and what treatment approaches may be required. The three main types of blood cancer are leukaemia, lymphoma, and multiple myeloma.

Leukaemia

Leukaemia starts in the bone marrow and affects the body’s ability to produce healthy white blood cells. These abnormal cells crowd out normal blood cells, leading to frequent infections, anaemia, and bleeding issues. Leukaemia can be acute (fast-growing) or chronic (slow-growing), and the type determines how quickly treatment needs to begin.

Lymphoma

Lymphoma develops in the lymphatic system, which helps the body fight infections. It causes abnormal lymphocytes to multiply in the lymph nodes and other lymphatic tissues. There are two main types: Hodgkin lymphoma, known for a specific type of cancer cell called the Reed–Sternberg cell, and Non-Hodgkin lymphoma, which includes many subtypes that vary widely in behaviour and treatment.

Multiple Myeloma

Multiple myeloma affects plasma cells, a type of white blood cell that helps produce antibodies. When these cells become cancerous, they build up in the bone marrow and interfere with normal blood production. This can lead to bone pain, fractures, kidney issues, and frequent infections.

Each type of blood cancer behaves differently, which is why accurate diagnosis and specialised evaluation are crucial for determining the most effective treatment approach.

Causes and Risk Factors of Blood Cancer

The exact cause of blood cancer is not fully understood, but certain factors can increase the likelihood of developing the disease. These influences vary by type of blood cancer and may involve a combination of genetic, environmental, and age-related changes. However, having one or more risk factors does not mean that blood cancer will occur, but it may increase the need for awareness and timely evaluation.

Common risk factors include:

• Genetic mutations: Certain gene changes or chromosomal abnormalities can increase susceptibility to blood cancers.
• Family history: A close relative with leukaemia, lymphoma, or myeloma may raise the risk, although most cases occur without a family link.
• Exposure to radiation or chemicals: Long-term exposure to high levels of radiation or chemicals such as benzene can contribute to risk.
• Viral infections: Some viral infections, such as Epstein–Barr virus (EBV) or HTLV-1, are associated with specific types of lymphoma and leukaemia.
• Weakened immune system: Individuals with immune disorders or those taking long-term immunosuppressive medicines may be at higher risk.
• Age-related factors: Many blood cancers are more common in older adults due to natural changes in bone marrow and immune function.
• Smoking: Linked to an increased risk of certain blood cancers, especially acute myeloid leukaemia (AML).

These risk factors help guide doctors in identifying individuals who may benefit from closer monitoring or early evaluation.

Early Signs and Symptoms of Blood Cancer

Blood cancer symptoms can vary widely depending on the type of cancer and how it affects the blood, bone marrow, or lymphatic system. Many symptoms are non-specific and may resemble common infections or routine health issues, which can delay diagnosis. Paying attention to persistent or unusual changes in the body is important for early evaluation.

Here are some symptoms that may be associated with blood cancer:

General symptoms

• Unexplained fatigue or weakness
• Persistent fever or recurring infections
• Unintentional weight loss
• Night sweats or persistent chills

Blood-related symptoms

• Easy bruising or frequent bleeding from minor injuries
• Prolonged bleeding from cuts or nosebleeds
• Anaemia-related symptoms such as dizziness or shortness of breath

Bone marrow and bone-related symptoms

• Bone or joint pain
• Frequent infections due to low white blood cell counts

Lymphatic symptoms

• Painless swelling of lymph nodes in the neck, armpits, or groin
• Fullness or discomfort in the abdomen due to an enlarged spleen

Symptoms in females

• Persistent fatigue
• Unusual or frequent infections
• Low iron levels despite adequate diet

Because these symptoms can arise from many other conditions, medical evaluation is important when they continue for several weeks or worsen over time.

How is Blood Cancer Diagnosed?

Diagnosing blood cancer involves a series of tests that help doctors understand how the blood cells, bone marrow, and lymphatic system are functioning. Because symptoms can resemble common infections or routine health concerns, multiple evaluations are often needed to confirm the diagnosis and determine the specific type of blood cancer. Common diagnostic methods include:

Blood tests

A complete blood count (CBC) and peripheral smear help identify abnormalities in red cells, white cells, and platelets. These tests may show low or high counts, immature cells, or other irregularities. Markers such as CRP may indicate inflammation but do not diagnose cancer.

Bone marrow aspiration and biopsy

A small sample of bone marrow is taken from the hip bone to examine the types, number, and appearance of blood-forming cells. This is one of the most important tests for diagnosing leukaemia, lymphoma, and multiple myeloma.

Imaging tests

Scans such as CT, MRI, or PET-CT help assess lymph nodes, organs, and bones to determine whether the disease has spread or is affecting internal structures.

Flow cytometry and immunophenotyping

These advanced laboratory tests identify specific markers on blood or bone marrow cells, helping doctors determine the exact subtype of blood cancer.

Genetic and molecular testing

These tests detect chromosomal changes or gene mutations that are important for diagnosis, treatment planning, and predicting how the cancer may behave.

Lymph node biopsy (for lymphoma)

If lymphoma is suspected, a lymph node sample may be removed and analysed to confirm the diagnosis and identify the specific type.

Together, these tests help specialists determine the type of blood cancer present and create a personalised treatment approach based on accurate, detailed information.

Blood Cancer Stages and Classification

Blood cancers are classified differently from solid tumours because they affect the blood, bone marrow, and lymphatic system rather than forming a single localised mass. Each type of blood cancer has its own method of staging or risk classification, which helps doctors understand how advanced the disease is and plan the most effective treatment.

Lymphoma (Hodgkin and Non-Hodgkin) Staging

Lymphoma follows a traditional staging system from Stage I to Stage IV based on how far the disease has spread within the lymphatic system or to other organs.

• Stage I: Involvement of a single lymph node region or one nearby structure.
• Stage II: Two or more lymph node regions on the same side of the diaphragm.
• Stage III: Lymph nodes on both sides of the diaphragm are affected.
• Stage IV: Spread to distant organs such as the liver, bone marrow, or lungs.

Multiple Myeloma Classification (ISS / R-ISS)

Multiple myeloma is not staged like solid cancers. Instead, it is classified using systems such as the International Staging System (ISS) or Revised ISS (R-ISS), which consider:

• Levels of proteins such as albumin and beta-2 microglobulin
• Genetic features of the cancer cells
• Presence of organ involvement, such as kidney damage or bone disease

These categories help predict prognosis and guide treatment intensity.

Leukaemia Classification

Leukaemia does not use a traditional staging system because the disease is found in the blood and bone marrow from the outset. Instead, doctors classify it based on:

• Acute vs chronic forms
• Cell type involved (lymphoid or myeloid)
• Genetic and molecular changes
• Risk groups such as favourable, intermediate, or high risk

These classifications help determine how quickly treatment needs to begin and which therapies may be most effective.

Treatment Options for Blood Cancer

Treatment for blood cancer depends on the specific type, its classification, genetic features, and how the disease is affecting blood counts, bone marrow, or lymphatic tissues. Specialists use a personalised approach to select therapies that target abnormal cells while supporting the body’s overall health. Most individuals receive a combination of treatments over time, guided by ongoing assessments and response to therapy. Treatment approach include:

Chemotherapy

Chemotherapy is one of the main treatments for many blood cancers. It uses medicines that target rapidly dividing cancer cells. These medicines may be given orally or through a vein and are usually delivered in cycles. Chemotherapy helps control disease, reduce cancer cell burden, and prepare some patients for bone marrow transplant when required.

Immunotherapy and Targeted Therapy

These treatments work by supporting the immune system or targeting specific changes within cancer cells.

• Immunotherapy: Includes monoclonal antibodies and other agents that help the immune system identify and attack cancer cells.
• Targeted therapy: Works on particular genetic or molecular abnormalities found in the cancer, making treatment more precise and effective for selected cases.

Radiation Therapy

Radiation Therapy may be used in certain forms of lymphoma or to treat specific areas affected by the disease, such as enlarged lymph nodes or painful bone lesions. It is typically used alongside other treatments rather than alone.

Bone Marrow Transplant (Stem Cell Transplant)

A bone marrow transplant replaces damaged or diseased bone marrow with healthy stem cells.

• Autologous transplant: Uses a person’s own stem cells.
• Allogeneic transplant: Uses stem cells from a matched donor.

Transplants are considered for certain cases of leukaemia, lymphoma, or multiple myeloma and require careful evaluation to determine suitability.

Supportive Therapies

Supportive treatments help manage symptoms and improve quality of life during cancer care. This may include blood transfusions, medicines to boost blood counts, antibiotics for infections, and treatments to protect bone health.

These treatment options allow specialists to create a comprehensive plan tailored to the type and behaviour of blood cancer, helping improve outcomes and long-term health.

Supportive and Long-Term Follow-Up Care

Supportive care is an important part of blood cancer management and continues throughout treatment and recovery. It helps ease symptoms, manage side effects, support emotional wellbeing, and improve overall quality of life. Long-term follow-up care ensures that any health changes are identified early and that individuals receive consistent guidance as they heal.

To understand the key areas covered in supportive and long-term care, the main components include:

Managing Treatment Side Effects

A multidisciplinary supportive care team, including oncology nurses, pain management specialists, nutrition experts, and rehabilitation professionals, helps address side effects such as fatigue, nausea, infections, and discomfort. Early management improves comfort and supports uninterrupted treatment.

Nutritional Counselling

Dieticians create personalised meal plans that support blood cell recovery, manage appetite changes, and help maintain energy levels. Nutrition guidance is especially important for individuals experiencing weight changes or digestive issues.

Psychological and Emotional Support

Counsellors and psychologists provide support for stress, anxiety, mood changes, and emotional adjustment during treatment. Access to support groups can also help build a sense of community and shared understanding.

Physical Rehabilitation

Physiotherapy and gentle exercise programmes help improve strength, mobility, and endurance, especially after intensive treatments such as chemotherapy or bone marrow transplant.

Monitoring Related Health Concerns

Regular medical follow-ups help manage conditions linked to blood cancer treatment, such as infections, anaemia, bone health issues, or reduced immunity. Ongoing check-ups help ensure timely intervention when needed.

What are the Chances of Cure for Blood Cancer?

The outlook for blood cancer varies depending on the type of cancer, how early it is diagnosed, and how well it responds to treatment. Many blood cancers are highly treatable, and some can be cured, especially when identified early and managed with the appropriate therapies. Specialists assess several medical factors to understand prognosis and select the most effective treatment approach for each individual.

Impact of Early Diagnosis

Early detection allows treatment to begin before the disease has advanced or caused significant bone marrow suppression. This often leads to better treatment responses and improved long-term outcomes. In many cases of acute leukaemia and lymphoma, starting treatment promptly can significantly influence the likelihood of remission and cure.

Cure Outlook by Type of Blood Cancer

Different blood cancers behave differently, so their chances of cure vary:

• Leukaemia: Certain types, especially acute lymphoblastic leukaemia (ALL) in children and chronic myeloid leukaemia (CML) in adults, have high cure or long-term control rates with modern treatments.
• Lymphoma: Many lymphomas, including Hodgkin lymphoma, are considered highly curable, especially when diagnosed early. Non-Hodgkin lymphoma has varied outcomes depending on the specific subtype.
• Multiple myeloma: While myeloma is typically considered a chronic but treatable condition, advances in therapy have significantly improved long-term survival and quality of life.

Factors Affecting Prognosis

Doctors consider several factors when evaluating the outlook for blood cancer:

• Type and subtype of cancer
• Age and overall health
• Genetic and molecular features of the cancer cells
• Stage or risk category at diagnosis
• Response to initial treatment
• Presence of infections or organ involvement

Long-Term Survival Trends

Advances in chemotherapy, targeted therapy, immunotherapy, and bone marrow transplant have steadily improved survival rates for many blood cancers over the past two decades. With continued progress in personalised medicine and supportive care, long-term remission and survival are becoming more achievable across multiple blood cancer types.

Life After Blood Cancer Treatment

Life after blood cancer treatment involves a period of physical recovery, emotional adjustment, and gradual return to everyday routines. With ongoing medical support and healthy lifestyle habits, many individuals resume normal activities and maintain a good quality of life. Survivorship care focuses on long-term health, monitoring, and overall wellbeing once the main phase of treatment is complete. This stage of care focuses on the following important aspects:

Follow-Up Care and Monitoring

Regular follow-up visits help doctors track recovery, monitor blood counts, and identify any changes that may need attention. These visits may include physical examinations, blood tests, and occasional imaging to ensure the body is healing well and that the treatment response is maintained.

Managing Long-Term Side Effects

Some individuals may experience lingering effects such as fatigue, reduced stamina, mild nerve changes, or bone health issues. Specialists provide guidance on managing these concerns through medicines, exercise plans, and supportive therapies to help restore strength and comfort.

Nutrition and Immunity Support

A balanced diet rich in whole grains, fruits, vegetables, lean proteins, and adequate hydration helps rebuild strength and supports immune function. Maintaining good hygiene, staying up to date with vaccinations, and seeking timely care for infections are important for long-term immunity.

Emotional and Psychological Care

Finishing treatment can bring relief but may also lead to new emotions such as anxiety or uncertainty. Counselling, support groups, and psychological services help individuals adjust to life after treatment, cope with stress, and build confidence for the future.

Why Choose RGCIRC for Blood Cancer Care?

Blood cancer treatment requires precise diagnosis, timely intervention, and coordinated care from multiple specialists. At Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), each step of the treatment pathway is guided by advanced medical expertise, evidence-based practice, and a strong patient-centred approach. As one of India’s leading cancer care institutions, RGCIRC provides comprehensive services that support individuals through diagnosis, treatment, and long-term recovery. The key strengths that make RGCIRC a trusted centre for blood cancer care include:

Specialised Haemato-Oncology Expertise

RGCIRC is home to experienced haemato-oncologists who manage all types of blood cancers, including leukaemia, lymphoma, and multiple myeloma. Their expertise spans complex diagnoses, personalised treatment planning, and advanced therapies tailored to each individual’s clinical needs.

Advanced Diagnostic and Imaging Facilities

With state-of-the-art diagnostic laboratories and imaging technologies such as CT, MRI, PET-CT, flow cytometry, and molecular testing, RGCIRC ensures accurate and timely evaluation. These tools help identify cancer type, detect genetic changes, and guide targeted treatment decisions.

Comprehensive Chemotherapy and Immunotherapy Services

The medical oncology unit at RGCIRC is equipped to deliver a full range of therapies, including chemotherapy, immunotherapy, and targeted treatments. Protocols are based on global standards and adapted to provide the safest and most effective care.

Dedicated Bone Marrow Transplant (BMT) Programme

RGCIRC offers both autologous and allogeneic bone marrow transplants supported by infection-controlled units and specialised transplant teams. The BMT programme follows stringent international guidelines to ensure safety and optimal outcomes for suitable patients.

Multidisciplinary Treatment Planning

Treatment decisions are made through collaborative tumour boards involving haemato-oncologists, radiologists, pathologists, nurses, and supportive care specialists. This approach ensures that each case receives expert input from multiple perspectives.

Holistic Supportive and Rehabilitation Services

From nutritional counselling to psychological support, pain management, and physiotherapy, RGCIRC provides a full spectrum of supportive services. These programmes help individuals manage side effects, maintain strength, and improve overall quality of life during and after treatment.

Clear Communication and Patient Guidance

The institute emphasises transparent communication, helping patients and families understand their diagnosis, treatment options, and care pathways. This clarity allows individuals to make informed decisions with confidence and reassurance.

Taking the Next Step Towards Better Health

Early awareness, timely diagnosis, and access to specialised care play an important role in improving outcomes for blood cancer. Understanding the symptoms, recognising risk factors, and seeking expert medical guidance can help ensure that treatment begins at the right time. At Rajiv Gandhi Cancer Institute & Research Centre, individuals receive comprehensive evaluation, evidence-based treatment, and long-term support tailored to their unique health needs.

To consult a cancer specialist at Rajiv Gandhi Cancer Institute & Research Centre, call +91-11-47022222, +91 11 27051037 or fill out our contact form and we will get back to you shortly.

Frequently Asked Questions (FAQs)

What are the early symptoms of blood cancer?

Early symptoms may include persistent fatigue, frequent infections, unexplained bruising, weight loss, or swollen lymph nodes. Any ongoing change should be evaluated by a doctor.

Can blood cancer be detected through a blood test?

A complete blood count (CBC) may show abnormal blood cell levels, which can suggest a problem. Further tests such as bone marrow examination, flow cytometry, or genetic testing are required for confirmation.

Are CRP levels linked to blood cancer?

CRP is not a test for cancer. It is an inflammation marker that may rise in infections or other conditions. Elevated CRP alone does not indicate blood cancer.

What are the main types of blood cancer?

The three major types are leukaemia, lymphoma, and multiple myeloma. Each affects different blood cells and requires specific diagnostic and treatment approaches.

Is blood cancer curable?

Some blood cancers, such as Hodgkin lymphoma, childhood ALL, and CML, have high cure or long-term control rates with modern treatment. Outcomes depend on the type of cancer, genetics, response to therapy, and overall health.

What treatment options are available for blood cancer near me in Delhi-NCR?

Treatment options may include chemotherapy, immunotherapy, targeted therapy, radiation therapy, or a bone marrow transplant, depending on the type of blood cancer. Individuals in Delhi-NCR can access complete and specialised care at centres such as RGCIRC.

Who is at higher risk of developing blood cancer?

Risk may be higher in individuals with certain genetic mutations, long-term chemical exposure, a weakened immune system, specific viral infections, or family history of blood cancer.